nasopharyngeal cancer การใช้
- EBV infection has been specifically associated with nasopharyngeal cancer.
- Nasopharyngeal cancer affects the nose and throat area.
- In a type of head and neck cancer known as nasopharyngeal cancer, the onco-protein kinase c-Met maintains TIGAR expression.
- There was demonstrable efficacy noted in nasopharyngeal cancer patients injected with LMP1 DNAzyme and allergic asthma patients following GATA3 DNAzyme inhalation.
- On January 22, 2015 it was revealed to the public that Chan was diagnosed with nasopharyngeal cancer and would be taking a leave of absence from Parliament while undergoing treatment.
- Researchers at Mount Sinai Hospital, near the heart of Toronto's Chinatown, believe the rate of nasopharyngeal cancer may be lower among the 350, 000 ethnic Chinese who immigrated to Toronto in the past 20 years.
- Further information and evaluation of all known data led the IARC to reclassify formaldehyde as a " known human carcinogen " associated with nasal sinus cancer and nasopharyngeal cancer, and possibly with leukaemia in June 2004.
- Seliciclib ( CYC202 or R-roscovitine ), a CDK ( cyclin dependent kinase ) inhibitor, is in Phase 2 studies for the treatment of lung cancer and nasopharyngeal cancer and in a Phase 1 trial in combination with sapacitabine.
- Although several studies have not shown a link between incense and Cancer " found that incense use is associated with a statistically significant higher risk of cancers of the upper respiratory tract, with the exception of nasopharyngeal cancer.
- This was later followed by numerous other independent, some multi-center, clinical trials evaluating DNAzymes in humans, including DNAzymes targeting EBV-LMP1 in patients with nasopharyngeal cancer and DNAzymes targeting another nuclear transcription factor GATA3 in patients with allergic asthma demonstrating DNAzyme efficacy and safety.
- According to a 2009 review : " Nimotuzumab was approved for the following indications For squamous cell carcinoma in head and neck ( SCCHN ) in India, Cuba, Argentina, Colombia, Ivory Coast, Gabon, Ukraine, Peru and Sri Lanka ( expired now ); for glioma ( pediatric and adult ) in Cuba, Argentina, Philippines and Ukraine; for nasopharyngeal cancer in China.